Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection, though this treatment is possible in less than 40% of patients. However, recent improvements in preoperative management have led to a higher number of patients who are candidates for this procedure. For unresectable patients, progress is ongoing in terms of locoregional and chemoradiation treatments and target therapies, especially in the definition of patient selection criteria. This is the second part of the Italian CCA guidelines, dealing with CCA treatment, that have been formulated in accordance with Italian National Institute of Health indications and developed according to the GRADE method and related advancements.

Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment / Alvaro, D.; Hassan, C.; Cardinale, V.; Carpino, G.; Fabris, L.; Gringeri, E.; Granata, V.; Mutignani, M.; Morement, H.; Giuliante, F.; Guglielmi, A.; Ridola, L.; Tonini, G.; Marzioni, M.; Grazi, G.; Guido, M.; Di Giulio, E.; Pantano, F.; Venere, R.; Bragazzi, M. C.; Biancanello, F.; Faccioli, J.; Giannetti, A.; Cintolo, M.; Di Giunta, M.; Gambato, M.; Lasagni, A.; Izzo, F.; Avallone, A.; Banales, J.; Rossi, M.; Catalano, C.; Laghi, A.; D'Amati, G.; Mancino, M. G.. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 9:(2020), pp. 1-13. [10.1016/j.dld.2020.08.030]

Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment

Alvaro D.;Cardinale V.;Carpino G.;Granata V.;Ridola L.;Marzioni M.;Grazi G.;Di Giulio E.;Venere R.;Bragazzi M. C.;Faccioli J.;Banales J.;Rossi M.;Laghi A.;D'amati G.;Mancino M. G.
2020

Abstract

Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection, though this treatment is possible in less than 40% of patients. However, recent improvements in preoperative management have led to a higher number of patients who are candidates for this procedure. For unresectable patients, progress is ongoing in terms of locoregional and chemoradiation treatments and target therapies, especially in the definition of patient selection criteria. This is the second part of the Italian CCA guidelines, dealing with CCA treatment, that have been formulated in accordance with Italian National Institute of Health indications and developed according to the GRADE method and related advancements.
2020
distal cholangiocarcinoma; intrahepatic cholangiocarcinoma; liver transplantation; locoregional treatments; perihilar cholangiocarcinoma; surgery; target therapies
01 Pubblicazione su rivista::01a Articolo in rivista
Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment / Alvaro, D.; Hassan, C.; Cardinale, V.; Carpino, G.; Fabris, L.; Gringeri, E.; Granata, V.; Mutignani, M.; Morement, H.; Giuliante, F.; Guglielmi, A.; Ridola, L.; Tonini, G.; Marzioni, M.; Grazi, G.; Guido, M.; Di Giulio, E.; Pantano, F.; Venere, R.; Bragazzi, M. C.; Biancanello, F.; Faccioli, J.; Giannetti, A.; Cintolo, M.; Di Giunta, M.; Gambato, M.; Lasagni, A.; Izzo, F.; Avallone, A.; Banales, J.; Rossi, M.; Catalano, C.; Laghi, A.; D'Amati, G.; Mancino, M. G.. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 9:(2020), pp. 1-13. [10.1016/j.dld.2020.08.030]
File allegati a questo prodotto
File Dimensione Formato  
Alvaro_Italian-clinical-practice_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.08 MB
Formato Adobe PDF
1.08 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1461084
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 37
social impact